Position in AGIO
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$38,959,099
+$11,620,939 QoQ
Shares Held
1,151,614
+14.7% QoQ
Ownership
1.94%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 93%
Shared 4%
None 3%
Common Shares in AGIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,907,830 across 224 Biotechnology names. AGIO ranks #32 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in AGIO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $38,959,099 | 1,151,614 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $27,338,160 | 1,004,341 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $40,991,006 | 1,021,201 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $36,788,651 | 1,106,093 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $36,978,736 | 1,262,073 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $43,673,074 | 1,329,065 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $69,407,788 | 1,562,183 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $94,695,182 | 2,196,085 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $75,397,035 | 2,578,558 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $57,829,932 | 2,596,764 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $60,857,551 | 2,458,891 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $64,111,323 | 2,263,818 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $48,038,330 | 2,091,351 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $46,418,455 | 1,653,079 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $41,808,839 | 1,478,389 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $29,777,788 | 1,343,157 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $29,419,031 | 1,010,616 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $23,843,930 | 725,401 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $24,943,982 | 540,498 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $15,638,730 | 283,773 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $14,986,237 | 290,206 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $12,598,674 | 290,761 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $11,396,210 | 325,606 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $18,211,330 | 340,526 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $13,664,980 | 385,146 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||